Medical Tests
Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.
Browse Directory Sections
All medical tests (102,751)
Other
NPM1 gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal
Blood test
NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
NR0B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
NR4A3 gene rearrangements in Blood or Tissue by FISH
Other
NRAS gene [VCF] in Cancer specimen by Sequencing
Blood test
NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Other
NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal
Other
NRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal
Blood test
NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method
Blood test
NSD1 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method
Blood test
NTRK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
NTRK gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Other
NTRK1 and NTRK2 and NTRK3 targeted gene mutation analysis in Tissue by Molecular genetics method
Other
NTRK1, NTRK2 and NTRK3 gene rearrangements in Tissue by Molecular genetics method
Blood test
NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method
Blood test
NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method
Blood test
NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method
Blood test
NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method
Blood test
NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method
Blood test
NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method
Blood test
NUDT15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Blood test
NUP98 11p15.4 gene rearrangement [Identifier] in Blood or Tissue by FISH Nominal
Blood test
NUTM1 gene rearrangements in Blood or Tissue by FISH
Blood test
NXP-2 Ab [Presence] in Serum or Plasma
Blood test
NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay
Blood test
Nabumetone [Mass/volume] in Serum or Plasma
Other
Nadolol [Mass/time] in 24 hour Urine
Blood test
Nadolol [Mass/volume] in Serum or Plasma
Other
Nadolol [Mass/volume] in Urine
Other
Nadolol [Mass] of Dose
Other
Nadolol [Measurement] in Urine
Blood test
Nadolol [Moles/volume] in Serum or Plasma
Other
Nadolol [Presence] in Urine
Other
Naegleria fowleri Ab [Measurement] in Cerebral spinal fluid
Other
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid
Other
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay
Other
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Other
Naegleria fowleri Ab [Presence] in Specimen by Immunofluorescence
Other
Naegleria fowleri Ag [Presence] in Specimen by Immunofluorescence
Other
Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Other
Naegleria fowleri DNA [Presence] in Specimen by NAA with probe detection
Other
Naegleria fowleri [Presence] in Specimen by Organism specific culture
Other
Naegleria sp identified in Tissue by Organism specific culture
Other
Naegleria sp identified in Tissue by Wet preparation
Blood test
Nafcillin [Mass/volume] in Serum or Plasma
Other
Nafcillin [Mass/volume] in Specimen
Other
Nafcillin [Susceptibility]
Other
Nafcillin [Susceptibility] by Disk diffusion (KB)
Other
Nafcillin [Susceptibility] by Gradient strip
Other
Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
Nafcillin [Susceptibility] by Minimum lethal concentration (MLC)
Other
Nafcillin [Susceptibility] by Serum bactericidal titer
Blood test
Nafcillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
Nafcillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Other
Nail angle Estimated
Other
Nail assessment panel
Other
Nails/calluses trimmed during last 90 days [Minimum Data Set]
Blood test
Nairobi sheep disease virus Ab [Measurement] in Serum
Blood test
Nairobi sheep disease virus Ab [Presence] in Serum
Blood test
Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID)
Blood test
Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence
Blood test
Nairobi sheep disease virus Ab [Titer] in Serum
Blood test
Nairobi sheep disease virus Ab [Units/volume] in Serum
Other
Nairobi sheep disease virus Ag [Presence] in Specimen
Other
Nairobi sheep disease virus Ag [Presence] in Specimen by Complement fixation
Other
Nairobi sheep disease virus Ag [Presence] in Specimen by Immunoassay
Other
Nairobi sheep disease virus Ag [Presence] in Specimen by Immunofluorescence
Other
Nakaseomyces bracarensis DNA [Presence] in Specimen by NAA with probe detection
Other
Nakaseomyces nivariensis DNA [Presence] in Specimen by NAA with probe detection
Other
Nalbuphine [Mass/time] in 24 hour Urine
Blood test
Nalbuphine [Mass/volume] in Serum or Plasma
Other
Nalbuphine [Mass/volume] in Specimen
Other
Nalbuphine [Mass/volume] in Urine
Other
Nalbuphine [Mass/volume] in Urine by Confirmatory method
Other
Nalbuphine [Mass] of Dose
Other
Nalbuphine [Measurement] in Urine
Other
Nalbuphine [Presence] in Urine
Other
Nalbuphine [Presence] in Urine by Confirmatory method
Other
Nalbuphine [Presence] in Urine by Screen method
Other
Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method
Other
Nalbuphine cutoff [Mass/volume] in Urine for Screen method
Blood test
Nalidixate [Mass/volume] in Serum or Plasma
Other
Nalidixate [Mass/volume] in Specimen
Other
Nalidixate [Susceptibility]
Other
Nalidixate [Susceptibility] by Disk diffusion (KB)
Other
Nalidixate [Susceptibility] by Gradient strip
Other
Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
Nalidixate [Susceptibility] by Minimum lethal concentration (MLC)
Other
Nalidixate [Susceptibility] by Serum bactericidal titer
Other
Nalorphine [Mass/volume] in Urine
Other
Nalorphine [Mass] of Dose
Other
Naloxol [Mass/volume] in Urine by Confirmatory method
Other
Naloxol cutoff [Mass/volume] in Urine for Confirmatory method
Other
Naloxone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Blood test
Naloxone [Mass/volume] in Serum or Plasma
Other
Naloxone [Mass/volume] in Urine
Other
Naloxone [Mass/volume] in Urine by Confirmatory method
Other
Naloxone [Measurement] in Urine